Enoxaparin and rivaroxaban have different effects on human mesenchymal stromal cells in the early stages of bone healing

OBJECTIVES: Venous thromboembolism (VTE) is a major potential complication following orthopaedic surgery. Subcutaneously administered enoxaparin has been used as the benchmark to reduce the incidence of VTE. However, concerns have been raised regarding the long-term administration of enoxaparin and...

Descripción completa

Detalles Bibliográficos
Autores principales: Pilge, H., Fröbel, J., Prodinger, P. M., Mrotzek, S. J., Fischer, J. C., Zilkens, C., Bittersohl, B., Krauspe, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852789/
https://www.ncbi.nlm.nih.gov/pubmed/26989119
http://dx.doi.org/10.1302/2046-3758.53.2000595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852789/
https://www.ncbi.nlm.nih.gov/pubmed/26989119
http://dx.doi.org/10.1302/2046-3758.53.2000595

Ejemplares similares